Quarterly report pursuant to Section 13 or 15(d)
Cover
Cover Page
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes to Financial Statements
Business
Basis of Presentation and Summary of Significant Accounting Policies
Going concern
Revenue
Cash and Cash equivalents
Prepaid and other assets
Property and equipment, net
Trade and other payables
Leases
Stockholders' equity
Income taxes
Commitments and contingencies
Related party transactions
Subsequent events
Accounting Policies
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
Notes Tables
Business (Tables)
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
Revenue (Tables)
Cash and Cash equivalents (Tables)
Prepaid and other assets (Tables)
Property and equipment, net (Tables)
Trade and other payables (Tables)
Leases (Tables)
Stockholders' equity (Tables)
Notes Details
Business - Summary of entities in control (Detail)
Basis of Presentation and Summary of Significant Accounting Policies - Summary of property and equipment (Detail)
Basis of Presentation and Summary of Significant Accounting Policies - Additional information (Detail)
Going concern - Additional information (Detail)
Revenue - Summary of revenue from customers (Detail)
Cash and Cash equivalents - Summary of cash and cash equivalent (Detail)
Prepaid and other assets - Summary of other current assets (Detail)
Property and equipment, net - Summary of property and equipment net (Detail)
Property and equipment, net - Additional information (Detail)
Trade and other payables- Summary of trade and other payables (Detail)
Leases - Summary of maturities of the operating lease liabilities (Detail)
Leases - Additional information (Detail)
Leases - Summary of supplemental balance sheet information related to leases (Detail)
Stockholders' equity - Schedule of warrants or rights (Detail)
Stockholders' equity - Schedule of equity awards (Detail)
Stockholders' equity - Summary of share-based compensation expense (Detail)
Stockholders' equity - Additional information (Detail)
Related party transactions - Additional information (Detail)
Business (Tables)
v3.21.2
Business (Tables)
3 Months Ended
Sep. 30, 2021
Schedule Of Entities In Control [Abstract]
Summary of entities in control
Principal place of
business/country of
incorporation
Benitec Biopharma Proprietary Limited (“BBL”)
Australia
Benitec Australia Proprietary Limited
Australia
Benitec Limited
United Kingdom
Benitec, Inc.
USA
Benitec LLC
USA
RNAi Therapeutics, Inc.
USA
Tacere Therapeutics, Inc.
USA
Benitec IP Holdings, Inc.
USA
X
- References
No definition available.
+ Details
Name:
bntc_ScheduleOfEntitiesInControlAbstract
Namespace Prefix:
bntc_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Schedule of entities in control.
+ References
No definition available.
+ Details
Name:
bntc_ScheduleOfEntitiesInControlTableTextBlock
Namespace Prefix:
bntc_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration